PriceSensitive

ECS Botanics (ASX:ECS) frees up funds with asset sales and new debt facility

ASX News, Health Care
ASX:ECS      MCAP $27.06M
22 July 2022 10:47 (AEST)

This browser does not support the video element.

Medicinal cannabis company, ECS Botanics (ECS) has launched the sale of two assets and secured a new loan facility.

The company agreed to sell its hemp food and wellness business for $250,000 to Ananda Food, with contract completion expected in August upon the finalisation of due diligence.

In addition, the company has planned to sell its Tasmanian medicinal cannabis facility, noting a high level of interest.

To bolster its funds further, ECS secured a $2 million commercial loan facility with NAB.

The non-dilutive funds received through the sales and loan will be used to expand medicinal cannabis production, with the goal of boosting future revenue.

Managing Director Nan-Maree Schoerie said she was pleased with how operations were progressing.

“The company is about to commence the stage three expansion which will look to double the secure cultivation area and the installation of more protective cropping capacity leveraging the available funds,” she said.

“Deploying the most appropriate funding maximises value and returns for our shareholders.”

Shares in the company were steady on the market, trading at 2.7 cents at 10:43 am AEST.

Related News